BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17237138)

  • 1. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.
    Jank T; Giesemann T; Aktories K
    Glycobiology; 2007 Apr; 17(4):15R-22R. PubMed ID: 17237138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and mode of action of clostridial glucosylating toxins: the ABCD model.
    Jank T; Aktories K
    Trends Microbiol; 2008 May; 16(5):222-9. PubMed ID: 18394902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the glucosyltransferase activity of clostridial Rho/Ras-glucosylating toxins by castanospermine.
    Jank T; Ziegler MO; Schulz GE; Aktories K
    FEBS Lett; 2008 Jun; 582(15):2277-82. PubMed ID: 18505687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
    Genth H; Dreger SC; Huelsenbeck J; Just I
    Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Super toxins from a super bug: structure and function of Clostridium difficile toxins.
    Davies AH; Roberts AK; Shone CC; Acharya KR
    Biochem J; 2011 Jun; 436(3):517-26. PubMed ID: 21615333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enzymatic domain of Clostridium difficile toxin A is located within its N-terminal region.
    Faust C; Ye B; Song KP
    Biochem Biophys Res Commun; 1998 Oct; 251(1):100-5. PubMed ID: 9790914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-cutting to kill: new insights into the processing of Clostridium difficile toxins.
    Aktories K
    ACS Chem Biol; 2007 Apr; 2(4):228-30. PubMed ID: 17455899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release.
    D'Urzo N; Malito E; Biancucci M; Bottomley MJ; Maione D; Scarselli M; Martinelli M
    FEBS J; 2012 Sep; 279(17):3085-97. PubMed ID: 22747490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large clostridial cytotoxins.
    Just I; Gerhard R
    Rev Physiol Biochem Pharmacol; 2004; 152():23-47. PubMed ID: 15449191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterization of the cell wall binding domains of Clostridium difficile toxins A and B; evidence that Ca2+ plays a role in toxin A cell surface association.
    Demarest SJ; Salbato J; Elia M; Zhong J; Morrow T; Holland T; Kline K; Woodnutt G; Kimmel BE; Hansen G
    J Mol Biol; 2005 Mar; 346(5):1197-206. PubMed ID: 15713474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity.
    Egerer M; Giesemann T; Jank T; Satchell KJ; Aktories K
    J Biol Chem; 2007 Aug; 282(35):25314-21. PubMed ID: 17591770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.
    Egerer M; Giesemann T; Herrmann C; Aktories K
    J Biol Chem; 2009 Feb; 284(6):3389-95. PubMed ID: 19047051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing of Clostridium difficile toxins.
    Giesemann T; Egerer M; Jank T; Aktories K
    J Med Microbiol; 2008 Jun; 57(Pt 6):690-696. PubMed ID: 18480324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile Toxin Biology.
    Aktories K; Schwan C; Jank T
    Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human alpha-defensins inhibit Clostridium difficile toxin B.
    Giesemann T; Guttenberg G; Aktories K
    Gastroenterology; 2008 Jun; 134(7):2049-58. PubMed ID: 18435932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins.
    Schirmer J; Aktories K
    Biochim Biophys Acta; 2004 Jul; 1673(1-2):66-74. PubMed ID: 15238250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
    Zeiser J; Gerhard R; Just I; Pich A
    J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
    Chen S; Sun C; Wang H; Wang J
    Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile toxin A-induced apoptosis is p53-independent but depends on glucosylation of Rho GTPases.
    Nottrott S; Schoentaube J; Genth H; Just I; Gerhard R
    Apoptosis; 2007 Aug; 12(8):1443-53. PubMed ID: 17437185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.